Silexion Therapeutics Corp financial statements
Silexion Therapeutics Corp's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 11.91M | 10-K |
| Cash and equivalents | USD 5.99M | 10-Q |
| Total debt | USD 468K | EODHD |
Silexion Therapeutics Corp financials on 6ix · Silexion Therapeutics Corp on 6ix